Immune-Mediated Thrombotic Thrombocytopenic Purpura: Early Diagnosis to Improve Patient Outcomes

This case series has been developed with the assistance of Dr. Tina Dutt (Consultant Haematologist and Director of the Liverpool TTP Specialist Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom). This activity was supported by Sanofi.

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labelling. Please note that products may have different product labelling according to geographic location. In the United Kingdom (UK), full prescribing information is available within the Electronic Medicines Compendium (medicines.org.uk/emc).

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for an audience of healthcare professionals registered to practice in the UK. To proceed, please confirm that you are a healthcare professional registered to practice in the UK.

Modules

• A 42-year-old woman with headache, peripheral numbness, and bruising.

• A 72-year-old with community-acquired pneumonia and thrombocytopenia